ANNA SHORT: Open Payments
NPI 1033428735 · ROELAND PARK, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$62,588 in 198 payments from 9 companies in 2025. Trend: 2023 $66,554 · 2024 $42,455 · 2025 $62,588
Speaker / faculty: $25,345Honoraria: $13,327Consulting: $12,590Travel & lodging: $7,825Food & beverage: $3,501
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 94 | $40,128 |
| Axsome Therapeutics, Inc. | 44 | $17,050 |
| PFIZER INC. | 42 | $4,903 |
| Lundbeck LLC | 10 | $198 |
| Novo Nordisk Inc | 1 | $121 |
| Amgen Inc. | 2 | $94 |
| Teva Pharmaceuticals USA, Inc. | 2 | $49 |
| AstraZeneca Pharmaceuticals LP | 2 | $28 |
| Gilead Sciences, Inc. | 1 | $18 |
Products named: QULIPTA, Symbravo, BOTOX, NURTEC ODT, UBRELVY, ZAVZPRET, VYEPTI, Ozempic.
Industry payments across KS — which companies pay providers there.
